To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

NCT00706719 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hypogonadism

Interventions

DRUG: 25 mg Androxal
DRUG: Testim 1%

Sponsor

Repros Therapeutics Inc.